In Vitro Fertilization (IVF) Service Market Size, Share, By Type (Fresh IVF Cycle, Thawed IVF Cycle, and Donor Egg IVF Cycle), End-User (Fertility Clinics, Hospitals, Surgical Centers, and Clinical Research Institutes), and Region - Trends, Analysis, and Forecast till 2034

• By 2034, the in vitro fertilization (IVF) service market size to be USD 4838.7 million.
• The market was worth at USD 1019.3 million in 2024.
• The market is expanding at a CAGR of 18.7% during the forecast period. 

In Vitro Fertilization is a form of reproductive technology applied to help the childless couple conceive. It involves a step-by-step process, beginning with ovarian stimulation. This is a stage wherein the woman will be administered hormone medication to stimulate her ovaries to produce many eggs. These will then be monitored carefully through blood tests and ultrasound to determine the best time to retrieve them. Rising infertility rates is expected to dominate the market growth during the forecast period.

Key Takeaways:

• North America is projected to dominate the market owing to the advanced healthcare infrastructure, high awareness, and favorable reimbursement policies.
• Asia Pacific is expected to experience exponential growth rate due to the increasing fertility, medical infrastructure improvements, and surged disposable income.

                             To Know More, Request Free Sample Report

Increasing Infertility Rates to Drive Market Growth

• At the global level, infertility rates are on the rise and are attributed to multi-causality. First and foremost, delayed childbearing is due to higher educational qualifications, a career, and becoming economically independent. Besides, lifestyle changes, including obesity and smoking, alcohol consumption, and environmental pollutants, all contribute to the decline in fertility. The emerging trends of underlying medical conditions, such as endometriosis, polycystic ovary syndrome, and low sperm count have further increased this problem. As a result, the mentioned factors have contributed toward a significant rise in the count of couples looking forward to medical assistance in conceiving.

Growing Adoption of Assisted Reproductive Technologies (ART) to Aid Market Growth

• The growing awareness and acceptance of ARTs, including IVF, as viable solutions to infertility have led to the growth of the market. The rigorous technological advancement in IVF procedures increases the success rate, and more couples are encouraged to go for such treatments. Another reason is the increasing range of services provided by ART, such as egg freezing, sperm donation, and gestational surrogacy, which cater to the diverse needs of patients.

Restraints:

High Cost of IVF Treatments May Hamper Market Growth

• The most significant obstacle to greater market penetration is still the high cost of IVF treatments. The total cost of medicines, consultations, and procedures is high and incurs unaffordable costs for a big section of the population. However, recent trends indicate a change in this scenario. Shared risk financing models, whereby some fertility clinics assume part of the financial burden in return for some share of potential revenue from any successful treatments, have shown promise in making IVF more accessible. Besides this factor, the growing availability of affordable generic fertility medications and the development of cost-effective laboratory techniques also contribute to gradual price reductions in treatment.

Opportunities:

Expansion of IVF Tourism to Boost Future Growth Opportunities

• Countries with advanced IVF infrastructure that can offer cost-effective treatments are now becoming medical tourism hubs. This has its area of huge opportunity for the IVF service market by treating international patients at affordable prices with quality care. This is likely to continue with further relaxation in regulations related to cross-border fertility treatment by more countries and an expansion in the global middle-class population. Moreover, developing telemedicine and online consultation further helps gain access for IVF services from centers across the globe, fueling IVF tourism.

The market is segmented into type, end-user, and region. 

By Type

By type, the market is trifurcated into fresh IVF cycle, thawed IVF cycle, and donor egg IVF cycle. The fresh IVF cycles segment holds the largest in vitro fertilization (IVF) service market share owing to their high success rates globally.

By End-User

On the basis of end-user, the market is classified into fertility clinics, hospitals, surgical centers, and clinical research institutes. The market is being dominated by the fertility clinics segment owing to their increased focus on providing IVF treatments globally.  

Regional Insights:

Based on geography, the market is studied across North America, Asia Pacific, Europe, Latin America, and the Middle East & Africa.

• North America: The major growth drivers for the North American market include advanced healthcare infrastructure, high awareness, and favorable reimbursement policies. In the United States, the largest market share in the region is attributed to a higher number of fertility clinics and an increasing demand for assisted reproductive technologies.
• Asia Pacific: At the moment, the Asia-Pacific region is growing at an exponential rate for the IVF market. This market is rising due to increasing infertility, medical infrastructure improvements, and increased disposable income. Countries, such as India and China are significant contributors, and medical tourism will increase the market in the region.

In Vitro Fertilization (IVF) Service Market Report Scope:

Segmentation:

By Type:

• Fresh IVF Cycle
• Thawed IVF Cycle
• Donor Egg IVF Cycle

By End-User:

• Fertility Clinics
• Hospitals
• Surgical Centers
• Clinical Research Institutes

By Region:

North America

• U.S.
• Canada

Europe

• Germany
• U.K.
• France
• Russia
• Italy
• Rest of Europe

Asia Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia Pacific

Latin America

• Brazil
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC
• Israel
• South Africa
• Rest of Middle East & Africa

The major competitors of the market include Columbia University Fertility Center, Shady Grove Fertility Center. Boston IVF, LLC., Houston Fertility Institute, and others. These key players in the market are launching new products and services to maintain competitive edge in the market.

List of Key Players in the Market:

• Columbia University Fertility Center
• Boston IVF, LLC.
• Shady Grove Fertility Center
• Fertility Centers of Illinois
• Cleveland Clinic Fertility Center
• Reproductive Medicine Associates
• Houston Fertility Institute
• Mayo Clinic Fertility Center
• Pacific Fertility Center
• Colorado Center for Reproductive Medicine

                     To Access More Companies, Download Free Sample PDF

• In May 2024, Gameto announced new data demonstrating the clinical-grade manufacturing of an in vitro maturation solution for fertility care. Gameto, a female-led biotechnology company on a mission to reinvent women's healthcare, today announced new research outlining the cellular engineering and manufacturing techniques underlying Fertilo, a novel investigational in vitro maturation (IVM) solution containing engineered ovarian support cells (OSCs) to mature eggs outside of the body.
• In January 2024, ReproTech launched Cryo-Logix, a new entity designed to provide in vitro fertilization clinics with a comprehensive, seamless, end-to-end cryostorage solution. Yo-Logix will function as an independent organization under ReproTech to enable IVF clinics to deliver better patient care from consent to disposition. Cryo-Logix's team will help to ease the administrative constraints that many IVF clinics encounter by handling billing, collections, patient outreach, logistics, and disposition of cryogenic inventory, whether held in the IVF clinic tank or at ReproTech.

More Related Reports

Infertility Treatment Market
In Vitro Fertilization Market
Fertility Drug Market
Virtual Hospitals Market
Surgical Navigation Systems Market